Home » MIV THERAPEUTICS TO UNVEIL TECHNOLOGIES TARGETING $23 BILLION ORTHOPEDICS DEVICE MARKET
MIV THERAPEUTICS TO UNVEIL TECHNOLOGIES TARGETING $23 BILLION ORTHOPEDICS DEVICE MARKET
August 11, 2006
MIV Therapeutics, a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, will unveil technology to address multiple revenue opportunities in the $23 billion orthopedic device market at the upcoming World Orthopedic Organization (SICOT) conference in Buenos Aires, later this month. Business Wire (http://home.businesswire.com/portal/site/home/?epi_menuItemID=989a6827590d7dda9cdf6023a0908a0c&epi_menuID=c791260db682611740b28e347a808a0c&epi_baseMenuID=384979e8cc48c441ef0130f5c6908a0c&ndmViewId=news_view&newsLang=en&div=294036369&newsId=20060810005716)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct